Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display

3268 - The time frame of palliative care referrals


09 Oct 2016


Poster display


Maja Ebert Moltara


Annals of Oncology (2016) 27 (6): 455-461. 10.1093/annonc/mdw384


M. Ebert Moltara

Author affiliations

  • Acute Palliative Care Departent, Institute of Oncology Ljubljana, 1000 Ljubljana - Ljubljana/SI


Abstract 3268


Today we have much strong evidence that supports the early integration of palliative care into standard cancer care of all the patients with incurable cancer. At our Institution we have stablished an Acute Palliative Care Department (APCD) in 2007 and today we can provide a specialist palliative care as inpatient, outpatient and consultation service. Aim: to analyse the time frame of the referrals to palliative care services at our institution.


We collected data on the entire patient population who were supported with specialist palliative care at our instuitions between 2007–2015. We have also compared triads - periods between 2007-2009, 2010-2012 and 2013-2015.


In the observed period 1842 palliative care patients (942 males, 913 females) have been served by at least one of the APCD services. At the time of the analyse 98% had already died. 99.9% of them had incurable cancer. 60% of them were treated at APCD inpatient unit, 23.5% at outpatient clinic and 15.9% were advised by specialist palliative care consultation team. The mean time of palliative care service referrals for the whole group and period was 54 days. When we compared the three triads between each other we observed a small trend to earlier referrals (2007-2009: 42days, 2010-2012: 51 days and 2013-2015: 61 days).


We observed earlier palliative care referrals in the last triad of the APCD existence at our institutions comparing first and second triad; still the referrals are late in the illness trajectory.

Clinical trial identification

Legal entity responsible for the study

Oncology Institute of Ljubljana


Oncology Institute of Ljubljana


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings